Evidence map›Paper›PMID 25605869›Full record

ReviewJournal of leukocyte biology2015

γδ T Cells and dendritic cells in refractory Lyme arthritis.

Ali Divan, Ralph C Budd, Richard P Tobin, M Karen Newell-Rogers

Abstract readReview
In one paragraph

Review in Journal of leukocyte biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Strain-specific immune response patterns toInfection and immunity · 2026
    Article
  2. Cell-Mediated Cytotoxicity in Lyme Arthritis.Arthritis & rheumatology (Hoboken, N.J.) · 2023
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Immune Response toCurrent issues in molecular biology · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ali Divan*Texas A&M Health Science, Temple, Texas, USA; and University of Vermont, Burlington, Vermont, USA.
Ralph C Budd*Texas A&M Health Science, Temple, Texas, USA; and University of Vermont, Burlington, Vermont, USA.
Richard P Tobin*Texas A&M Health Science, Temple, Texas, USA; and University of Vermont, Burlington, Vermont, USA.
M Karen Newell-Rogers*Texas A&M Health Science, Temple, Texas, USA; and University of Vermont, Burlington, Vermont, USA mnewellrogers@sw.org.
Temple College · USUniversity of Vermont · US

Funding

Vermont Immunobioloigy/ Infectious Diseases CenterP20GM103496 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2012 to 2015
$8.7M
GAMMA DELTA T CELLS IN LYME ARTHRITISR01AR043520 · NIAMS · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI BUDD, RALPH C · 1994 to 2011
$3.8M
NIAMS NIH HHS R01 AR043520NIGMS NIH HHS P20 GM103496
6 · The paper itself

Abstract

Lyme disease is a multisystem infection transmitted by tick vectors with an incidence of up to 300,000 individuals/yr in the United States. The primary treatments are oral or i.v. antibiotics. Despite treatment, some individuals do not recover and have prolonged symptoms affecting multiple organs, including the nervous system and connective tissues. Inflammatory arthritis is a common symptom associated with Lyme pathology. In the past decades, γδ T cells have emerged as candidates that contribute to the transition from innate to adaptive responses. These cells are also differentially regulated within the synovia of patients affected by RLA. Here, we review and discuss potential cellular mechanisms involving γδ T cells and DCs in RLA. TLR signaling and antigen processing and presentation will be the key concepts that we review in aid of understanding the impact of γδ T cells in RLA.

Indexed as

AnimalsAntigen PresentationAntigens, BacterialAntigens, Differentiation, B-LymphocyteApoptosisBorrelia burgdorferiCaspasesChronic DiseaseDendritic CellsDisease Models, AnimalFas Ligand Proteinfas ReceptorHistocompatibility Antigens Class IIHLA-DR AntigensHumansInfectionsAntigens, BacterialAntigens, Differentiation, B-LymphocyteCaspasesFASLG protein, humanFas Ligand ProteinFAS protein, humanfas ReceptorHistocompatibility Antigens Class IIHLA-DR AntigensInterleukin-17invariant chainLipoproteinsN-palmitoyl-S-(2,3-bis(palmitoyloxy)propyl)cysteinyl-seryl-lysyl-lysyl-lysyl-lysineReceptors, Antigen, T-Cell, gamma-deltaTLR2 protein, humanToll-Like Receptor 2caspaseCd1CLIPFaspolyarthritisToll-like receptor

Identifiers

PMID25605869
PMCPMC4763954
OpenAlexW2056746119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.